Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04327648
Other study ID # XH-20-004
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 1, 2020
Est. completion date December 30, 2023

Study information

Verified date March 2020
Source Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Contact Fei Li
Phone +86-21-25077461
Email feili@shsmu.edu.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Current study try to find out whether social interaction treatment is effective for ASD children. ASD children will be divided into three groups, social interaction treatment group, neuronal cognition treatment and routine treatment group. Based on excited recognition training treatment effect on the core symptom of ADHD by tablet computer, the investigators propose that tablet computer social interaction treatment may induce a significant improvement in ameliorating the social disorder of ASD.


Description:

Appropriate and effective treatment coupled with home training can help ASD children restore the ability of language, behavior and learning. However, there is no suitable and effective behavior intervention for home training yet. Current study try a 3 months' randomized double-blinded clinical trial to find out whether tablet computer social interaction treatment at home is effective for ASD children. 90 3-6 years old ASD children will be included and divided into three groups, social interaction treatment group, neuronal cognition treatment and routine treatment group respectively. During the treatment days, children in social interaction treatment group will have 30min social interaction each day for 3 months. Children in neuronal cognition treatment group will experienced neural cognition training 30min each day for 3 months. Children in routine treatment group will keep the same initial treatment. All ASD children are followed up closely. The primary observed indicator is the score of Childhood Autism Rating Scale (CARS) at the inclusion, one month and 3 month after treatment to evaluate the effect of tablet computer social interaction treatment on ASD children.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 90
Est. completion date December 30, 2023
Est. primary completion date December 30, 2023
Accepts healthy volunteers No
Gender All
Age group 3 Years to 6 Years
Eligibility Inclusion criteria:

- Patients diagnosed with ASD. Diagnostic criteria: diagnosed by pediatric psychiatrists in accordance with the criteria in the Fifth Edition of Diagnostic and Statistical Manual of Mental Disorders (DSM-V), Autism Diagnostic Observation Schedule (ADOS) and Autism Diagnostic Interview-Revised (ADI-R)

- CARS = 34

- Agree to sign the informed consent

Exclusion criteria:

- Children with abnormal gene and chromosome

- Children with neurodevelopmental diseases (like epilepsy, schizophrenia)

- Children with severe sense perception disorder

- Children with weight over 20kg, with electronic metal products in body unsuited for magnetic resonance imaging

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Social interaction treatment
Children in social interaction treatment group will have 30min social interaction each day for 3 months.
Neuronal cognition treatment
Children in neuronal cognition treatment group will experienced neural cognition training 30min each day for 3 months.
Other:
Routine treatment
Children in routine treatment group will keep the same initial treatment.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Outcome

Type Measure Description Time frame Safety issue
Other Head magnetic resonance imaging (MRI) Head MRI is used to detect the structure and function of the brain. Changes in the head MRI results of the subject before and after treatment. The baseline and 3 months after treatment
Other Head functional Near infra-red spectroscopy (fNIRs) Head fNIRs is a non-invasive, non-ionizing method for measuring and imaging the functional hemodynamic response to brain activity. It measures changes in hemoglobin (Hb) concentrations within the brain by means of the characteristic absorption spectra of Hb in the near-infrared range. Changes in the head fNIRs results of the subject before and after treatment. The baseline and 3 months after treatment
Primary Childhood Autism Rating Scale, (CARS) CARS is a behaviour-rating scale used to assess the presence and severity of the symptoms of autism spectrum disorder(ASD), with scores ranging from 15 to 60 and high scores indicating severe symptoms. Change of the CARS from baseline to 3 months after treatment to evaluate the effect of tablet computer social interaction treatment on ASD children. The baseline and 3 months after treatment
Secondary Social responsiveness scale, (SRS) SRS is a questionnaire used to assess the presence and severity of social impairment, with high scores indicating severe symptoms. Change of the SRS from baseline to 3 month after treatment to evaluate the effect of computer social interaction treatment on ASD children. The baseline and 3 months after treatment
Secondary Autism Diagnostic Observation Schedule, ADOS The ADOS is a structured play session conducted by clinicians, with the total score combines the Social and Communication domain items, with high scores indicating severe symptoms. Change of the ADOS from baseline to 3 months after treatment to evaluate the effect of tablet computer social interaction treatment on ASD children. The baseline and 3 months after treatment
Secondary Clinical Global Impression, CGI CGI is a scale used to assess the severity of the illness and the global improvement of the patient under intervention The baseline and 3 months after treatment
See also
  Status Clinical Trial Phase
Completed NCT02847182 - Cord Blood Infusion for Children With Autism Spectrum Disorder Phase 2
Completed NCT02708290 - Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD
Completed NCT04771338 - Examining the Effects of a Job Entry Intervention N/A
Completed NCT04178421 - Computerized Eye-tracking Attention Training for Children With Special Needs N/A
Completed NCT02985749 - A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder Phase 3
Recruiting NCT06012903 - Lower Urinary Tract Symptoms and School Functioning in Children
Not yet recruiting NCT04418921 - Improving Self-regulation in Children With Neurodevelopmental Disorders: N/A
Completed NCT01931033 - An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders N/A
Recruiting NCT04899544 - Trial of Center-Based vs. In-Home Pivotal Response Treatment (PRT) in Autism N/A
Recruiting NCT06155214 - Developmental Regression-related Disease Research and Achievement Transformation Innovation Team
Active, not recruiting NCT01932515 - Diagnostic Instruments for Autism in Deaf Children Study N/A
Recruiting NCT06188429 - Peripheral Blood VA/TREM2 Levels and Their Correlation Analysis With the Development and Autistic Symptoms in Children With ASD
Completed NCT06209463 - Posture, Hand Functions and Sensory Processing Skills on Nutrition
Recruiting NCT06155201 - Development and Application of Intelligent Diagnosis and Treatment Norms for Children and Adolescents With Mental Disorders N/A
Recruiting NCT03502239 - Cognitive Rehabilitation (Mega Team) and Its Effects on Emotional and Behavioral Regulation in ADHD, ASD, and CHD N/A
Withdrawn NCT03829878 - Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT) Phase 2
Recruiting NCT02461446 - Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
Completed NCT03900923 - Cannabidiol for ASD Open Trial Phase 2
Recruiting NCT06339359 - A Pilot Study to Develop a Behavior-based Screening Protocol for Early Diagnosis of Autism Spectrum Disorders
Completed NCT03099239 - hCT-MSCs for Children With Autism Spectrum Disorder (ASD) Phase 1